| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,334 |
4,046 |
$178K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,097 |
4,717 |
$117K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,957 |
3,463 |
$63K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,999 |
5,961 |
$53K |
| 80061 |
Lipid panel |
3,774 |
3,285 |
$49K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
781 |
755 |
$39K |
| 80053 |
Comprehensive metabolic panel |
3,566 |
3,102 |
$36K |
| 86328 |
|
1,618 |
1,566 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
821 |
706 |
$22K |
| 81000 |
|
5,037 |
4,325 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
1,663 |
1,609 |
$14K |
| 86703 |
|
1,026 |
895 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,200 |
1,036 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,268 |
1,089 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
158 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
502 |
315 |
$7K |
| 82274 |
|
357 |
312 |
$6K |
| 87109 |
|
176 |
162 |
$2K |
| 82043 |
|
347 |
283 |
$2K |
| 87088 |
|
222 |
174 |
$2K |
| 85651 |
|
217 |
167 |
$740.96 |
| 86803 |
|
53 |
40 |
$719.03 |
| 84436 |
|
100 |
74 |
$668.72 |
| 86769 |
|
21 |
21 |
$603.68 |
| 86592 |
|
139 |
109 |
$581.65 |
| 84439 |
|
52 |
40 |
$498.42 |
| 83970 |
|
12 |
12 |
$459.01 |
| 82270 |
|
125 |
96 |
$406.63 |
| 83655 |
|
44 |
32 |
$405.65 |
| 86738 |
|
24 |
24 |
$325.27 |
| 82947 |
|
65 |
58 |
$220.66 |
| 82607 |
|
14 |
13 |
$219.87 |
| 82950 |
|
14 |
14 |
$69.73 |